Viruses reproduce by hijacking a living cell’s own machinery, forcing it to manufacture viral components and assemble new virus particles. Because viruses carry no ribosomes, no energy-generating systems, and in many cases no enzymes of their own, they are obligate parasites: every new copy depends entirely on the host cell’s resources. The process unfolds in a series of distinct steps, from initial attachment through to the release of newly formed virions, and while the details vary dramatically between virus families, the broad logic is remarkably consistent.
Attachment and Finding the Right Cell
Replication begins the moment a virus particle drifts close enough to a compatible host cell. On the virus surface sit proteins (or glycoproteins) that recognize and latch onto specific molecules, called receptors, on the host cell membrane. This interaction is highly selective. A virus that infects your respiratory tract typically cannot infect your liver cells, because the two tissues display different surface molecules. The match between viral surface proteins and host receptors is the first factor determining which tissues a virus can attack, and it also influences how severe the resulting disease is.
Research on avian coronaviruses illustrates this selectivity well. When scientists compared the binding behavior of spike proteins from coronavirus strains with different tissue preferences, they found that the attachment patterns closely correlated with which organs each strain could infect. A strain that caused kidney disease bound kidney cells but barely touched respiratory tissue, while a respiratory strain did the opposite.1PubMed Central. Binding of avian coronavirus spike proteins to host factors reflects virus tropism and pathogenicity This principle applies broadly: surface protein interactions between virus and host cell, the availability of the cell’s internal machinery, and the host’s immune defenses all shape which cells a virus can productively infect.2Preprints. Molecular Engineering of Virus Tropism
Getting Inside
Binding to the cell surface is just the beginning. The virus still needs to deliver its genetic material into the cell’s interior, and how it accomplishes this depends heavily on whether the virus has a lipid envelope. Enveloped viruses, like influenza and HIV, are wrapped in a membrane stolen from a previous host cell. These viruses fuse their envelope directly with the host cell membrane, or with an internal compartment membrane after being swallowed into the cell, dumping their contents into the cytoplasm.3PubMed Central. Virus entry paradigms Non-enveloped viruses, like norovirus and adenovirus, lack this outer membrane. They generally enter by being taken up into small membrane-bound bubbles (endosomes) and then punch through or rupture the endosomal membrane to escape into the cytoplasm.4PubMed Central. Non-enveloped virus membrane penetration: New advances leading to new insights
The distinction matters because it creates different vulnerabilities. An enveloped virus that fuses membranes can be blocked by drugs that jam the fusion machinery, whereas a non-enveloped virus that punches pores in a membrane requires a different kind of intervention.
Uncoating and Releasing the Genome
Once inside the cell, the virus must shed its protective protein shell, or capsid, to free its genome. This step, called uncoating, is not a single event but a choreographed sequence triggered by specific cues inside the cell: changes in acidity, the presence of particular enzymes, or interactions with cellular structures.5PubMed Central. Principles of Virus Uncoating: Cues and the Snooker Ball
Influenza provides one of the best-studied examples. The virus rides inside an endosome as the compartment gradually acidifies. Researchers found that releasing the influenza genome requires two separate drops in pH. The first, from roughly neutral to about pH 6, loosens the capsid structure in a reversible way. The second, below pH 6, triggers an irreversible collapse: the internal matrix protein falls away, and a proton channel in the viral envelope floods the particle’s interior with hydrogen ions, finishing the job. If either step is skipped or if the proton channel is blocked, proper genome release fails.6PubMed Central. pH-Controlled two-step uncoating of influenza virus This is actually how the flu drug amantadine was designed to work: it clogs that proton channel.
Getting to the Nucleus, If Needed
Many viruses replicate entirely in the cytoplasm, but some need the nucleus. DNA viruses like herpesviruses, adenoviruses, and hepatitis B must get their genomes through the nuclear pore, a tightly regulated gateway. This is not trivial: the nuclear pore is selective, and large molecules do not pass freely.
Different viruses have evolved different tricks. Hepatitis B virus capsids, for instance, are imported whole through the nuclear pore. The intact capsid docks at the pore’s inner basket and then disassembles right there, releasing the viral DNA into the nucleus.7PubMed Central. Nuclear import of hepatitis B virus capsids and release of the viral genome This import depends on chemical modifications to the capsid protein and on the cell’s own transport machinery.8PubMed Central. Nuclear entry of DNA viruses Some viruses go further: certain viral proteins mimic the cell’s own nuclear transport signals, effectively tricking the pore into letting them pass.9PubMed. Visualizing Viral Transport Through the Nuclear Pore by Cryo-Electron Microscopy and Cryo-Electron Tomography
How Different Viruses Copy Their Genomes
Here is where viral replication diverges most sharply between virus families, because the strategy a virus uses to copy its genetic material depends on what kind of genome it carries.
DNA Viruses
Double-stranded DNA viruses replicate in ways that are, at least superficially, familiar. They use DNA polymerases to copy their genomes, much as your own cells do. But viral DNA polymerases have their own features. In some families, such as adenoviruses, the polymerase initiates copying by attaching directly to a terminal protein at the end of the genome rather than using the RNA primers that human cells employ. Large bacteriophages and big eukaryotic DNA viruses use polymerases that combine built-in proofreading with high processivity, meaning they copy long stretches of DNA without falling off the template.10Nature. DNA Polymerase Mechanisms in Viral Replication
Positive-Sense RNA Viruses
Positive-sense RNA viruses, a category that includes SARS-CoV-2, dengue, and hepatitis C, carry a genome that can be read directly by the cell’s ribosomes as though it were a messenger RNA. As soon as that genome enters the cytoplasm, ribosomes latch on and start translating it into proteins, including the virus’s own RNA-copying enzyme, called RNA-dependent RNA polymerase (RdRp). The virus then uses this enzyme to make a mirror-image (negative-sense) RNA copy, which serves as a template for producing many new positive-sense genomes.11PubMed Central. Introduction to RNA Viruses
Coronaviruses add a twist. Their RdRp (a protein called nsp12) is not very active on its own. It requires cofactors, nsp7 and nsp8, that clamp it onto the RNA template and keep it from falling off during copying. Without those cofactors, replication stalls.12PubMed Central. Replication of the coronavirus genome: A paradox among positive-strand RNA viruses
Negative-Sense RNA Viruses
Negative-sense RNA viruses, such as Ebola, rabies, and measles, face a special challenge. Their genome is the reverse complement of a usable message, so the cell’s ribosomes cannot read it. The virus must first transcribe its genome into a positive-sense copy using an RdRp that it brings along inside the virion. Without that pre-packaged polymerase, the genome is essentially locked and unreadable at the moment of entry. This is why negative-sense viruses must carry their own copying enzyme, while positive-sense viruses can afford to encode it and have the cell make it after infection.
Retroviruses
Retroviruses, most famously HIV, do something entirely different. They carry an RNA genome but convert it to double-stranded DNA using a viral enzyme called reverse transcriptase. That DNA copy is then inserted into the host cell’s own chromosomes by another viral enzyme, integrase.13PubMed Central. Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication Once integrated, the viral DNA, now called a provirus, is read by the cell’s normal transcription machinery whenever the gene is active, producing new viral RNA and proteins. This integration is what makes HIV so difficult to cure: the provirus hides in the cell’s own DNA and persists for the lifetime of that cell.14PubMed Central. Retroviral reverse transcriptases
Taking Over the Cell’s Protein-Making Machinery
Copying the genome is only half the job. The virus also needs the cell to manufacture its structural and functional proteins. Because viruses do not carry their own ribosomes, they must commandeer the host’s protein synthesis equipment, and many have evolved aggressive ways to do this.
Some RNA viruses destroy or disable the cell’s own translation initiation factors, the molecules that normally guide ribosomes to the beginning of host messenger RNAs. By cutting these factors or locking them up, the virus shuts down host protein production while its own messages continue to be read. Poliovirus, for instance, uses a viral protease to cleave a key initiation factor, crippling the cell’s ability to translate its own genes while viral RNA, which uses an alternative mechanism to recruit ribosomes, keeps getting translated.15PubMed Central. Coronavirus takeover of host cell translation and intracellular antiviral response: a molecular perspective
SARS-CoV-2 takes a different approach. One of its proteins, Nsp1, physically plugs the ribosome’s mRNA entry channel, blocking host messages from getting in. Viral mRNAs carry special leader sequences that allow them to bypass this blockade. The result is the same: the cell’s own genes go silent while the virus’s genes are read preferentially.16PubMed Central. Coronavirus takeover of host cell translation and intracellular antiviral response: a molecular perspective Some viruses have even evolved structured RNA elements called internal ribosome entry sites (IRESs) that recruit ribosomes directly, bypassing normal start signals entirely.17PubMed Central. The Hinge Region of the Israeli Acute Paralysis Virus Internal Ribosome Entry Site Directs Ribosomal Positioning, Translational Activity, and Virus Infection
Viral Factories and Replication Organelles
Viruses do not scatter their replication components randomly through the cell. Many positive-sense RNA viruses, in particular, remodel the host cell’s internal membranes, especially the endoplasmic reticulum, to create enclosed compartments where genome copying, protein production, and early assembly all happen in one concentrated spot. These structures go by various names: replication organelles, viral factories, or viroplasms.
Flaviviruses like dengue and Zika, for example, induce the cell’s endoplasmic reticulum to form inward-bulging pockets that serve as protected workshops for RNA replication.18PubMed Central. The organization and dynamics of viral factories These organelles are not just convenient workbenches. They concentrate viral and host proteins in one place to speed up replication, and they shield viral RNA from the cell’s own defenses, including enzymes that would chew up exposed foreign RNA.19PubMed Central. Host Subcellular Organelles: Targets of Viral Manipulation Viruses also reorganize the host cell’s internal skeleton, the cytoskeleton, to support these factory structures and shuttle components around the cell.20PubMed Central. Host cytoskeleton and membrane network remodeling in the regulation of viral replication
Assembly and Genome Packaging
Once enough copies of the genome and enough structural proteins have been manufactured, new virus particles begin to assemble. There are two broad strategies. In one, the capsid proteins and the genome come together simultaneously: the protein subunits wrap around the nucleic acid as they build the shell, so the genome is packaged during construction. In the other, an empty protein shell forms first, and the genome is then pushed inside by an energy-consuming molecular motor.21PubMed Central. Dynamics of viral self-assembly, viral genome packaging, and virus-cell interactions studied by optical tweezers
The co-assembly route is common among single-stranded RNA viruses, where electrostatic attraction between positively charged capsid proteins and negatively charged RNA helps drive the process. Experiments with a plant virus showed that packaging works properly only when the ratio of protein to RNA reaches a specific threshold corresponding to a charge balance between the two.22PubMed Central. Self-Assembly of Viral Capsid Protein and RNA Molecules of Different Sizes: Requirement for a Specific High Protein/RNA Mass Ratio The motor-driven route, by contrast, is typical of double-stranded DNA bacteriophages: the stiff, densely packed DNA genome is threaded into a pre-built shell under considerable pressure.23Soft Matter. Viruses as supramolecular self-assemblies: modelling of capsid formation and genome packaging
Maturation After Assembly
For some viruses, assembly does not produce an immediately infectious particle. Retroviruses, for example, initially bud from the cell as immature, non-infectious particles. Their structural proteins are synthesized as long polyprotein chains that must be cut at precise locations by a viral protease. This cleavage triggers a dramatic internal rearrangement: what was a disorganized ball of proteins reorganizes into a condensed, cone-shaped or spherical core that is now infectious.24PubMed. Retroviral proteases and their roles in virion maturation In HIV, this processing happens in an ordered sequence, with different cut sites in the polyprotein being cleaved at different rates, ensuring that the structural rearrangement proceeds step by step.25PubMed Central. Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites This is exactly the step targeted by HIV protease inhibitor drugs, which block the enzyme responsible for these cuts and leave the virus stuck in its immature, non-infectious form.
Release From the Cell
The final step is escape. How new virions get out depends on the virus. Non-enveloped viruses often exit by simply lysing the cell, rupturing it and spilling out in large numbers. Enveloped viruses typically bud through the cell membrane, wrapping themselves in a piece of the host’s own lipid bilayer as they go. This budding process frequently relies on the cell’s own membrane-sculpting machinery, particularly a system called ESCRT that the cell normally uses to pinch off internal membrane bubbles.
HIV, for example, encodes short amino acid sequences called late domains that recruit ESCRT components to the site where new particles are forming, allowing the membrane to pinch off around the budding virion. Research has shown that this same strategy extends beyond retroviruses: classical swine fever virus, a flavivirus, also hijacks the ESCRT-associated protein ALIX to facilitate budding, suggesting the approach is widespread.26PubMed Central. Classical swine fever virus recruits ALIX and ESCRT-III to facilitate viral budding
When Viruses Go Dormant Instead
Not every infection follows the full replication cycle right away. Some viruses can enter a state of latency, persisting in the host cell without producing new virions. Herpesviruses are the classic example: after initial infection, herpes simplex virus retreats into nerve cells, where its DNA is silenced by chemical modifications that lock the genes shut. It can remain dormant for years until a stress signal flips the switch, reversing the silencing and restarting active replication.27PubMed Central. Epigenetics and Genetics of Viral Latency
HIV latency works differently. The virus integrates its DNA into the host genome, and whether that provirus stays silent or becomes active depends partly on random fluctuations in how actively the cell reads that stretch of DNA. This stochastic noise in gene expression can function like a molecular coin flip, tipping the balance toward dormancy or active production of new viruses.28PubMed Central. NOISE IN VIRAL GENE EXPRESSION AS A MOLECULAR SWITCH FOR VIRAL LATENCY Even bacteriophages face this choice. Temperate phages that infect bacteria can either destroy their host immediately (the lytic path) or integrate into the bacterial chromosome and lie dormant as a prophage (the lysogenic path), reactivating later when conditions change.29PubMed. Molecular Basis of Lysis-Lysogeny Decisions in Gram-Positive Phages
Why Mistakes in Copying Matter
RNA viruses are famously sloppy copiers. Their RNA-dependent RNA polymerases lack the proofreading ability that many DNA polymerases possess, so errors accumulate rapidly with each round of replication. This high mutation rate is a double-edged sword. It allows virus populations to evolve quickly, adapting to new hosts, dodging immune responses, and developing drug resistance. But it also produces many defective genomes that cannot produce viable offspring.
When the error rate gets pushed even higher, viruses start generating large quantities of defective interfering particles, incomplete genomes that compete with functional ones for cellular resources. These aberrant products arise when the polymerase jumps to a distant location on the template without releasing the strand it is building, producing a truncated or rearranged genome.30PubMed Central. Defective Interfering Particles of Negative-Strand RNA Viruses Research on alphaviruses showed that when the polymerase was engineered to be even less accurate than normal, recombination rates climbed and defective particle production surged, weakening the virus in living hosts.31PubMed Central. Low-Fidelity Polymerases of Alphaviruses Recombine at Higher Rates To Overproduce Defective Interfering Particles This principle underlies a class of antiviral strategies aimed at pushing viral mutation rates past the point of viability, sometimes called lethal mutagenesis.
Antiviral Drugs Target Specific Steps
Understanding the replication cycle in this much detail is not just academic curiosity; it directly informs drug design. Modern antivirals are built to jam a specific step in the cycle. Entry inhibitors block attachment or membrane fusion. Reverse transcriptase inhibitors and integrase inhibitors target the retroviral-specific steps of genome conversion and chromosomal insertion. Polymerase inhibitors like remdesivir interfere with RNA copying. And protease inhibitors prevent the maturation cleavage that turns immature particles into infectious ones.32PubMed. Targeting Key Stages of the Viral Entry and Life Cycle: A Comprehensive Overview of the Mechanisms of Antiviral Actions
The logic of combination therapy follows naturally from the multi-step nature of the cycle. HIV treatment uses drugs hitting three or more different steps simultaneously, making it exponentially harder for the virus to evolve resistance to all of them at once. The same principle is increasingly being explored for other chronic viral infections.
How Bacteriophages Differ
Bacteriophages, the viruses that infect bacteria, follow the same general replication logic but face a unique physical challenge: getting through the rigid bacterial cell wall. Many phages have evolved elaborate injection devices for this purpose. The T4 phage, which infects E. coli, has a contractile tail that works like a syringe. When the phage binds irreversibly to the bacterial surface, its tail sheath contracts, driving an inner tube through the cell wall. A protein at the tip of this tube has enzyme activity that degrades the wall material, clearing a path for genome injection.33PubMed Central. Enzymes and Mechanisms Employed by Tailed Bacteriophages to Breach the Bacterial Cell Barriers Other phages with long, flexible tails use a different approach: they eject an internal tube protein that inserts across the cell envelope and carries wall-degrading enzyme domains to help punch through.
Once inside, phage replication proceeds through genome copying, protein synthesis, and assembly much as it does in animal viruses. The major difference at the end of the cycle is exit: lytic phages produce an enzyme called a lysin that digests the bacterial cell wall from the inside, bursting the cell open and releasing dozens to hundreds of new phage particles in a single event. This explosive release is why phage therapy, the use of bacteriophages to treat bacterial infections, is attracting renewed interest as antibiotic resistance grows.